Comparison of coasting with cabergoline administration for prevention of early severe Ovarian Hyper Stimulation Syndrome in Assisted Reproductive Technology cycles.

Trial Profile

Comparison of coasting with cabergoline administration for prevention of early severe Ovarian Hyper Stimulation Syndrome in Assisted Reproductive Technology cycles.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Cabergoline (Primary) ; Chorionic gonadotropin; Progesterone
  • Indications Ovarian hyperstimulation syndrome
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top